Omzo review

The homepage and terms disagree

Omzo's public terms list compounded semaglutide at $199 for the first month and $299 for follow-up months. Tirzepatide is listed at $349 initially and $399 for follow-up months. Those figures conflict with homepage prices of $179 and $279. The lower semaglutide amount appears in the terms as an original price, while the lower tirzepatide homepage amount is not established there as the applicable offer. Obtain a written quote before deciding which advertisement applies to you.

The follow-up figures are especially important for a recurring budget. An initial $199 or $349 charge is not the same as the later $299 or $399 charge, even if the service includes the same broad components. Ask whether your prescribed dose and supply fit those amounts, whether any commitment applies, and when the second payment occurs. A good quotation should resolve the homepage conflict rather than leaving you to infer that the smallest visible number will remain available.

The quoted package includes medication

Omzo describes the package as including consultation, a prescription, medication, shipping, and ongoing support. These are not advertised merely as care fees with the medication automatically purchased elsewhere. Still, the actual order should identify what is supplied and the refill interval. Ask whether any extra clinical appointment or prescription change creates another charge. An included-support statement is useful, but it does not establish every detail of the continuing clinical relationship.

The service also lists branded Ozempic at $1,299 and branded Zepbound at $1,399 for all listed months. Keep those routes separate from the compounded offers. A shared ingredient or familiar brand reference does not make a compounded formulation equivalent to an FDA-approved product. Compare the actual medication and complete charge available to you, including any insurance or manufacturer eligibility that may affect another route. Omzo's published cash package is not a universal price for all patients using a brand elsewhere.

Ask who provides the medicine and care

The public legal information does not clearly name the operating entity or dispensing pharmacy. Request the business name, medical group, assigned clinician, and actual pharmacy before paying. Those details serve different purposes: a company name identifies the seller, a clinician's licensure identifies who can treat you, and the pharmacy identity tells you who dispenses the prescription. A polished brand and a bundled price cannot supply those answers on their own.

Omzo displays a LegitScript seal and claims nationwide availability. A displayed seal is not independent confirmation of current certification, and a nationwide claim should still be checked against your address and proposed prescription. Ask how to verify the clinician serving your state. For a compounded product, also confirm the formulation, concentration, quantity, storage, and instructions. Omzo explicitly distinguishes compounded products from approved brands; preserve that distinction when discussing what you would receive.

Ongoing support needs practical terms

Before joining, ask how clinical questions are handled, whether follow-up is scheduled, and how to stop another order. Cancellation and refunds are separate questions, especially once medication has been prepared or shipped. The bundled support promise does not establish an unlimited response guarantee or a refund for an interrupted course. Written answers should explain when payment happens and what you need to do if you decide not to continue.

Omzo may appeal to someone wanting one quoted package that includes medication and shipping, with both compounded and branded routes described. The internal price conflict and missing entity and pharmacy details make confirmation essential. If pregnancy planning, breastfeeding, or postpartum circumstances matter, discuss them individually rather than assuming specialist support from general wellness language. Choose on the confirmed prescription, renewal charge, and accessible care, keeping the disputed homepage amounts separate from a reliable ongoing budget.